Aisling Capital LLC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 74 filers reported holding ADMA BIOLOGICS INC in Q3 2019. The put-call ratio across all filers is 3.79 and the average weighting 0.6%.

Quarter-by-quarter ownership
Aisling Capital LLC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2019$16,056,000
+15.0%
3,608,1710.0%35.46%
+53.2%
Q2 2019$13,964,000
+2.1%
3,608,1710.0%23.14%
+12.6%
Q1 2019$13,675,000
+58.6%
3,608,1710.0%20.55%
+741.5%
Q4 2018$8,624,000
-61.5%
3,608,1710.0%2.44%
-49.6%
Q3 2018$22,407,000
+37.7%
3,608,1710.0%4.84%
+126.7%
Q2 2018$16,273,000
-2.0%
3,608,1710.0%2.14%
-27.8%
Q1 2018$16,598,000
+43.3%
3,608,1710.0%2.96%
+29.3%
Q4 2017$11,582,000
+4.2%
3,608,1710.0%2.29%
+25.3%
Q3 2017$11,113,000
-16.8%
3,608,1710.0%1.83%
-20.1%
Q2 2017$13,350,000
-24.2%
3,608,1710.0%2.29%
-28.7%
Q1 2017$17,608,000
-4.7%
3,608,1710.0%3.21%
-25.4%
Q4 2016$18,474,000
-29.4%
3,608,1710.0%4.30%
-20.3%
Q3 2016$26,159,000
+21.8%
3,608,1710.0%5.39%
+6.3%
Q2 2016$21,469,000
-26.5%
3,608,1710.0%5.07%
-13.3%
Q1 2016$29,190,000
+0.2%
3,608,1710.0%5.84%
+16.4%
Q4 2015$29,118,000
-3.5%
3,608,1710.0%5.02%
-5.3%
Q3 2015$30,164,000
-9.7%
3,608,1710.0%5.30%
+6.6%
Q2 2015$33,412,000
-5.5%
3,608,1710.0%4.98%
+7.5%
Q1 2015$35,360,000
-12.3%
3,608,1710.0%4.63%
-24.3%
Q4 2014$40,303,0003,608,1716.11%
Other shareholders
ADMA BIOLOGICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 4,000,000$15,520,00013.71%
Stonepine Capital Management, LLC 6,940,000$26,927,20011.33%
Caligan Partners LP 2,676,093$10,383,2418.64%
Altium Capital Management LP 2,870,000$11,135,6005.66%
AWM Investment Company, Inc. 6,015,000$23,338,2003.36%
EAM Investors, LLC 1,749,598$6,788,4401.40%
Perceptive Advisors 11,900,255$46,172,9891.30%
EAM Global Investors LLC 836,323$3,244,9330.84%
Potomac Capital Management, Inc. 120,000$4660.54%
OBERWEIS ASSET MANAGEMENT INC/ 536,900$2,083,1720.44%
View complete list of ADMA BIOLOGICS INC shareholders